MX9300839A - ANTIOXIDANT DIARYL TELLS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. - Google Patents

ANTIOXIDANT DIARYL TELLS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Info

Publication number
MX9300839A
MX9300839A MX9300839A MX9300839A MX9300839A MX 9300839 A MX9300839 A MX 9300839A MX 9300839 A MX9300839 A MX 9300839A MX 9300839 A MX9300839 A MX 9300839A MX 9300839 A MX9300839 A MX 9300839A
Authority
MX
Mexico
Prior art keywords
diaryl
tells
antioxidant
procedure
contain
Prior art date
Application number
MX9300839A
Other languages
Spanish (es)
Inventor
Carl-Magnus Andersson
Mats Berglund
Ralph Brattsand
Ian Cotgreave
Lars Engman
Anders Hallberg
Peter Moldeus
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MX9300839A publication Critical patent/MX9300839A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/02—Anti-oxidant compositions; Compositions inhibiting chemical change containing inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C395/00—Compounds containing tellurium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen nuevos telururos de diarilo, de acuerdo con la fórmula (I) que son útiles como antioxidantes para la prevención o el tratamiento de desórdenes provocados o que involucran el daño oxidante al tejido.Novel diaryl tellurides are described according to formula (I) which are useful as antioxidants for the prevention or treatment of disorders caused or involving oxidative damage to tissue.

MX9300839A 1992-02-20 1993-02-17 ANTIOXIDANT DIARYL TELLS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. MX9300839A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9200502A SE9200502D0 (en) 1992-02-20 1992-02-20 NOVEL ANTIOXIDANTS

Publications (1)

Publication Number Publication Date
MX9300839A true MX9300839A (en) 1993-09-01

Family

ID=20385374

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300839A MX9300839A (en) 1992-02-20 1993-02-17 ANTIOXIDANT DIARYL TELLS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Country Status (12)

Country Link
CN (1) CN1083472A (en)
AP (1) AP9300490A0 (en)
AU (1) AU3580893A (en)
HR (1) HRP930179A2 (en)
IL (1) IL104683A0 (en)
IS (1) IS3977A (en)
MX (1) MX9300839A (en)
SE (1) SE9200502D0 (en)
SI (1) SI9300099A (en)
TN (1) TNSN93018A1 (en)
WO (1) WO1993016993A1 (en)
ZA (1) ZA93781B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686254A (en) * 1995-06-07 1997-11-11 Johnson & Johnson Clinical Diagnostics, Inc. Reduction in first slide bias and improved enzyme stability by the incorporation of diaryl tellurides in thin-film immunoassay elements
US5928886A (en) * 1995-06-07 1999-07-27 Johnson & Johnson Clinical Diagnostics, Inc. Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film, immunoassay elements
IL146694A (en) 2001-11-22 2010-12-30 Biomas Ltd Use of an aqueous solution containing a biologically active complex of tellurium dioxide for manufacturing a medicament
GB0227348D0 (en) * 2002-11-22 2002-12-31 Exeter Antioxidant Therapeutic Redox catalyst compositions
AU2004304716B2 (en) * 2003-12-18 2010-05-27 Biomas Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
US8840934B2 (en) * 2009-01-02 2014-09-23 Rainbow Pharmaceutical Sa Uses of ammonium chloride
JP5515029B2 (en) * 2009-09-11 2014-06-11 学校法人北里研究所 New organic telluronium and selenonium compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2195539A (en) * 1938-08-12 1940-04-02 Standard Oil Dev Co Di-alkyl diphenol sulphides
EP0198277B1 (en) * 1985-04-12 1989-05-03 A. Nattermann & Cie. GmbH Diseleno-bis-benzamides of primary and secondary amines, processes for their production and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
TNSN93018A1 (en) 1994-03-17
SI9300099A (en) 1994-09-30
WO1993016993A1 (en) 1993-09-02
AU3580893A (en) 1993-09-13
CN1083472A (en) 1994-03-09
IL104683A0 (en) 1993-06-10
ZA93781B (en) 1993-08-20
IS3977A (en) 1993-08-21
AP9300490A0 (en) 1994-08-18
SE9200502D0 (en) 1992-02-20
HRP930179A2 (en) 1994-10-31

Similar Documents

Publication Publication Date Title
CO4910163A1 (en) PREVENTION OF THE LOSS AND RESTORATION OF THE BONE MASS BY CERTAIN PROSTAGLANDIN AGONISTS
ECSP003682A (en) COMPOUNDS FOR THE TREATMENT OF THE ISCHEMIA
ES2186015T3 (en) DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL.
CR20120007A (en) 2-INDOLINONES REPLACED WITH PROTEINQUINASE INHIBITING PIRROLS (DIVISIONAL EXP. 6728)
ATE276241T1 (en) ANTIOXIDANT
GR1000392B (en) Stabilized compositions comprising an epidermic growth agent
PA8462301A1 (en) COMBINATION OF AN ALDOSA REDUCTASE INHIBITOR AND A GLUCOGEN PHOSPHORYLASE INHIBITOR
PT659402E (en) COMPOSITIONS CONTAINING CAROTENOIDS AND PROCAROTENOIDS COMBINED WITH POLYPHENOES FOR THE PREVENTION OF DAMAGE DUE TO AN ABNORMAL PRODUCTION OF FREE RADICALS.
ES2058185T3 (en) DERIVATIVES OF CAMPTOTECINA AND PROCEDURE FOR ITS PREPARATION.
HK1023946A1 (en) Novel antioxidant mixture.
AR007241A1 (en) ANALOGS OF 20-EPI-16-ENO OF VITAMIN D3, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND USE OF SUCH COMPOUNDS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS
BRPI0415179A (en) amide derivatives such as ion channel ligands and pharmaceutical compositions and methods of employing them
PA8485601A1 (en) AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS.
AR007135A1 (en) BENZOFURANE AND BENZOPYRANE COMPOUNDS, PHARMACEUTICAL FORMULATIONS CONTAINING THEM AND METHODS FOR PREPARING THE COMPOUNDS AND FORMULATIONS
ES2052603T3 (en) DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
UY26889A1 (en) PHARMACEUTICAL COMPOUNDS
MX9308005A (en) HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
ES2157524T3 (en) DISELENUROS AND SELENOSULFURES USED AS ANTIOXIDANT AGENTS.
PA8467301A1 (en) NEW DERIVATIVES OF DIHYDROXYHEXANIC ACID
DK1032556T3 (en) Pharmaceutically active compounds and methods of use
MX9300839A (en) ANTIOXIDANT DIARYL TELLS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX9300628A (en) NEW DERIVATIVES OF TAXANE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES2177811T3 (en) USE OF NITROFLAVONOIDS FOR THE TREATMENT OF ANXIETY.
ES2123499T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS.
MX9305510A (en) COMPOUNDS FOR THE TREATMENT OR PROPHYLAXIS OF GASTROINTESTINAL, CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEM DISORDERS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.